1481. Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline.
The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2013 on lipid management and treatment of all adults and children with chronic kidney disease (CKD). All forms of CKD are included (non-dialysis-dependent, dialysis-dependent, and kidney transplant recipients).
1498. Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians.
作者: Amir Qaseem.;Linda L Humphrey.;Nick Fitterman.;Melissa Starkey.;Paul Shekelle.; .
来源: Ann Intern Med. 2013年159卷11期770-779页
The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the treatment of anemia and iron deficiency in adult patients with heart disease.
1499. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis.
Recent interest has focused on a unique subgroup of overweight and obese individuals who have normal metabolic features despite increased adiposity. Normal-weight individuals with adverse metabolic status have also been described. However, it remains unclear whether metabolic phenotype modifies the morbidity and mortality associated with higher body mass index (BMI).
1500. Treatment of anemia in patients with heart disease: a systematic review.
作者: Devan Kansagara.;Edward Dyer.;Honora Englander.;Rongwei Fu.;Michele Freeman.;David Kagen.
来源: Ann Intern Med. 2013年159卷11期746-757页
The benefits of anemia treatment in patients with heart disease are uncertain.
|